Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
The article discusses the modern principles of lipid-lowering therapy and approaches to its administration in terms of levels of cardiovascular risk. The characteristics of groups of patients with different levels of cardiovascular risk (from low to high) in primary prevention are given. The article...
Guardado en:
Autores principales: | Marina G. Bubnova, Marianna Y. Ilchenko, Petr A. Lebedev |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Concilium Medicum
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f5a0142ea2a45fc9cae20eea8f53e85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Statins and diabetes: focus on pitavastatin
por: Soreiia A. Urazgildeeva
Publicado: (2020) -
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Sydney B Long, et al.
Publicado: (2010) -
Impact of adherence, patient perception, and knowledge to statin therapy – A cross-sectional study
por: Siddhi Umarje, et al.
Publicado: (2021) -
Normative data on cardiovascular autonomic function in Greenlandic Inuit
por: Jesper Fleischer, et al.
Publicado: (2021) -
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Peter Rossing, et al.
Publicado: (2021)